L

Lepu Biopharma
2157

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$7.87B
EV
HK$8.24B
Shares Outstanding
1.71B
Beta
-0.14

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
HK$4.69
P/E 2025E
-
P/Revenue 2025E
19.49x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Lepu Biopharma Co., Ltd.

gainify

L

Lepu Biopharma Co., Ltd.

2157

Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for cancer targeted therapy and immunotherapy in China and internationally. The company offers PUYOUHENG (Pucotenlimab Injection), a humanized ...

Sector

Healthcare

Industry

Biotechnology

CEO

Sui, Ziye

Employees

498

IPO Date

2022-02-23

Headquarters

No. 651, Lianheng Road, Minhang District, Shanghai 201612, China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved